is semaglutide being banned A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company GLP-1 weight-loss drugs are a

The session provides an overview of the currently available GLP-1 products for generic products to reference

muciniphila-based research into precision therapeutic interventions

The presence of GLP-1 receptors in testicular tissue and evidence of direct, weight-loss-independent effects on sperm function raises the possibility that GLP-1 drugs may act on male reproductive biology through two distinct mechanisms simultaneously: one systemic (through metabolic improvement) and one local (through direct testicular signaling)

You get a comprehensive support system

Wegovy is given as a shot that you take once a week